StonvexLoading…
StonvexStonvexStonvexCore line items from URI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.69B | $3.59B | $3.40B | $2.50B |
Operating Income | $3.97B | $4.07B | $3.83B | $3.23B |
Net Income | $2.49B | $2.58B | $2.42B | $2.10B |
EPS (Diluted) | $38.61 | $38.69 | $35.28 | $29.65 |
Total Assets | $29.87B | $28.16B | $25.59B | $24.18B |
Total Liabilities | $20.90B | $19.54B | $17.46B | $17.12B |
Cash & Equivalents | $459.00M | $457.00M | $363.00M | $106.00M |
Free Cash Flow OCF − CapEx | Not available | $416.00M | $840.00M | $743.00M |
Shares Outstanding | 63.10M | 65.31M | 67.27M | 69.36M |